Search research articles
Contact Us
Filters
Showing results (131-140 of 163) with videos related to
Page
of 17
Sort By:
The Journal of Infectious Diseases
|
February 9, 2012
Pharmacovigilance of malaria intermittent preventive treatment in infants coupled with routine immunizations in 6 African countries
Alexandra de Sousa, Leon Paul Rabarijaona, Ofori Tenkorang, et al.
BMC Dermatology
|
December 16, 2015
Risk factors associated with abscess formation among patient with leg erysipelas (cellulitis) in sub-Saharan Africa: a multicenter study
Palokinam Vincent Pitché, Bayaki Saka, Ahy Boubacar Diatta, et al.
The Lancet. Microbe
|
December 19, 2024
Artemether-lumefantrine-amodiaquine or artesunate-amodiaquine combined with single low-dose primaquine to reduce Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a five-arm, phase 2, single-blind, randomised controlled trial
Almahamoudou Mahamar, Leen N Vanheer, Merel J Smit, et al.
The Lancet. Microbe
|
May 5, 2024
Artemether-lumefantrine with or without single-dose primaquine and sulfadoxine-pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2, single-blind, randomised clinical trial in Ouelessebougou, Mali
Almahamoudou Mahamar, Merel J Smit, Koualy Sanogo, et al.
BMC Medicine
|
October 26, 2016
Efficacy of artemether-lumefantrine in relation to drug exposure in children with and without severe acute malnutrition: an open comparative intervention study in Mali and Niger
Lise Denoeud-Ndam, Alassane Dicko, Elisabeth Baudin, et al.
Cytokine
|
February 11, 2023
IFNγ, TNFα polymorphisms and IFNγ serum levels are associated with the clearance of drug-resistant P. falciparum in Malian children
Bourema Kouriba, Charles Arama, Dinkorma T Ouologuem, et al.
Plos Medicine
|
August 14, 2025
The transmission blocking activity of artemisinin-combination, non-artemisinin, and 8-aminoquinoline antimalarial therapies: A pooled analysis of individual participant data
Leen N Vanheer, Jordache Ramjith, Almahamoudou Mahamar, et al.
Plos One
|
October 18, 2007
Impact of a Plasmodium falciparum AMA1 vaccine on antibody responses in adult Malians
Alassane Dicko, David J Diemert, Issaka Sagara, et al.
Vaccine
|
October 31, 2009
A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults
Issaka Sagara, Ruth D Ellis, Alassane Dicko, et al.
The Lancet. Microbe
|
May 11, 2022
Single low-dose tafenoquine combined with dihydroartemisinin-piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial
Will Stone, Almahamoudou Mahamar, Merel J Smit, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 163) with videos related to
Sort By:
Page
of 17
The Journal of Infectious Diseases
|
February 9, 2012
Pharmacovigilance of malaria intermittent preventive treatment in infants coupled with routine immunizations in 6 African countries
Alexandra de Sousa, Leon Paul Rabarijaona, Ofori Tenkorang, et al.
BMC Dermatology
|
December 16, 2015
Risk factors associated with abscess formation among patient with leg erysipelas (cellulitis) in sub-Saharan Africa: a multicenter study
Palokinam Vincent Pitché, Bayaki Saka, Ahy Boubacar Diatta, et al.
The Lancet. Microbe
|
December 19, 2024
Artemether-lumefantrine-amodiaquine or artesunate-amodiaquine combined with single low-dose primaquine to reduce Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a five-arm, phase 2, single-blind, randomised controlled trial
Almahamoudou Mahamar, Leen N Vanheer, Merel J Smit, et al.
The Lancet. Microbe
|
May 5, 2024
Artemether-lumefantrine with or without single-dose primaquine and sulfadoxine-pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2, single-blind, randomised clinical trial in Ouelessebougou, Mali
Almahamoudou Mahamar, Merel J Smit, Koualy Sanogo, et al.
BMC Medicine
|
October 26, 2016
Efficacy of artemether-lumefantrine in relation to drug exposure in children with and without severe acute malnutrition: an open comparative intervention study in Mali and Niger
Lise Denoeud-Ndam, Alassane Dicko, Elisabeth Baudin, et al.
Cytokine
|
February 11, 2023
IFNγ, TNFα polymorphisms and IFNγ serum levels are associated with the clearance of drug-resistant P. falciparum in Malian children
Bourema Kouriba, Charles Arama, Dinkorma T Ouologuem, et al.
Plos Medicine
|
August 14, 2025
The transmission blocking activity of artemisinin-combination, non-artemisinin, and 8-aminoquinoline antimalarial therapies: A pooled analysis of individual participant data
Leen N Vanheer, Jordache Ramjith, Almahamoudou Mahamar, et al.
Plos One
|
October 18, 2007
Impact of a Plasmodium falciparum AMA1 vaccine on antibody responses in adult Malians
Alassane Dicko, David J Diemert, Issaka Sagara, et al.
Vaccine
|
October 31, 2009
A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults
Issaka Sagara, Ruth D Ellis, Alassane Dicko, et al.
The Lancet. Microbe
|
May 11, 2022
Single low-dose tafenoquine combined with dihydroartemisinin-piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial
Will Stone, Almahamoudou Mahamar, Merel J Smit, et al.
Page
of 17